Cancer Biomarker Market Business Insights
August 1, 2024 — The global cancer biomarker market, valued at USD 23.03 billion in 2023, is anticipated to experience robust growth, with projections indicating it will reach USD 58.93 billion by 2032. This expansion reflects a compound annual growth rate (CAGR) of 11.60% over the forecast period from 2024 to 2032, driven by increasing demand for...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian